Tag: Health Care

Displaying 281 - 300 of 811 results.

The FTC challenged Laboratory Corporation of America’s $57.5 million acquisition of rival clinical laboratory testing company Westcliff Medical Laboratories, Inc., alleging that the transaction would lead to higher prices and lower quality in the Southern California market for the...
The Federal Trade Commission testified today before Congress on how it protects and promotes competition in the health care industry to help make sure U.S. consumers get high-quality care at competitive prices. Continuing effective antitrust enforcement is a critical part of any plan to improve...
As part of its ongoing efforts to ensure competition in U.S. health care markets, the Federal Trade Commission today challenged Laboratory Corporation of America’s $57.5 million acquisition of rival clinical laboratory testing company Westcliff Medical Laboratories, Inc., alleging that the...
The FTC required Universal Health Services, Inc., one of the nation’s largest hospital management companies, to sell 15 psychiatric facilities as a condition of its $3.1 billion acquisition of Psychiatric Solutions, Inc. As originally proposed the acquisition would have reduced...
The Federal Trade Commission will require Universal Health Services, Inc., one of the nation’s largest hospital management companies, to sell 15 psychiatric facilities as a condition of its $3.1 billion acquisition of Psychiatric Solutions, Inc. The proposed settlement is the latest example of the...
On October 5, 2010, the Federal Trade Commission will co-host a workshop on several issues associated with Accountable Care Organizations (ACOs), organizations authorized by the new Affordable Care Act that seek to deliver high-quality and efficient health care services to consumers. Joining the...
In a letter issued today, the staff of the Federal Trade Commission advised Yakima Valley Memorial Hospital that its proposal to provide pharmaceuticals purchased at a discount to employees of two affiliate entities is exempt from the Robinson-Patman Act, a U.S. antitrust law that prohibits anti-...
At the request of the Federal Trade Commission, a U.S. district court has ordered the marketers of acai berry supplements, “colon cleansers,” and other products to temporarily halt an Internet sales scheme that allegedly scammed consumers out of $30 million or more in 2009 alone through deceptive...
In a letter issued today, the staff of the Federal Trade Commission advised Community CarePartners, Inc. that its proposal to provide pharmaceuticals purchased at a discount to in-home hospice patients is exempt from the Robinson-Patman Act, a U.S. antitrust law that prohibits anticompetitive...
The Minnesota Rural Health Cooperative (MRHC), comprised by a group of doctors and hospitals in southwestern Minnesota, agreed to a settlement with the Federal Trade Commission that prohibits anticompetitive tactics the group allegedly used to increase health insurance reimbursement...
A group of doctors and hospitals in southwestern Minnesota has agreed to a settlement with the Federal Trade Commission that prohibits anticompetitive tactics the group allegedly used to increase health insurance reimbursement rates. Under a proposed settlement order, the Minnesota Rural Health...
The FTC issued an administrative complaint on 7/17/2010 alleging that the state dental board in North Carolina is harming competition by blocking non-dentists from providing teeth-whitening services in the state.
In a speech to the American Medical Association in Chicago, Federal Trade Commission Chairman Jon Leibowitz announced that the FTC will hold a public workshop this fall on health care competition policy, payment reform, and the new models for delivering health care that seek to incentivize high-...
FTC Files Amicus Brief in Support of Rehearing of Ciprofloxacin "Pay-for-Delay" Case The Federal Trade Commission has filed an amicus brief in the U.S. Court of Appeals for the Second Circuit, recommending that it hold a rehearing before all the judges ("en banc") of the Ciprofloxacin (Cipro) "pay...
An amicus brief in support of plaintiffs-appellants’ petition for rehearing en banc. The case concerns a court of appeals panel decision upholding the dismissal of an antitrust challenge to a Hatch-Waxman patent settlement. Because of the “exceptional importance” of the issues...
Federal Trade Commission Chairman Jon Leibowitz issued the following statement regarding today’s decision by the U.S. Court of Appeals for the Second Circuit, which invited the plaintiffs in the Ciprofloxacin drug patent settlement case to seek further review by the full court of appeals because...
In a letter issued today, the staff of the Federal Trade Commission advised the University of Michigan that a proposed modification to reduce costs for its drug benefit program for employees, retirees, and their dependants is exempt from the Robinson-Patman Act, a U.S. antitrust law that prohibits...
The Federal Trade Commission has approved a proposed divestiture by Virginia-based health care company Carilion Clinic. Under a December 2009 settlement with the FTC, Carilion must divest a medical imaging center and an outpatient surgical center in Roanoke, Virginia, to FTC-approved buyers. That...

Pages